SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Dynavax Technologies Corp. & Advises Investors to Contact th...
November 18 2016 - 1:16PM
Business Wire
Goldberg Law PC, a national shareholder rights litigation
firm, announces that it is investigating Dynavax Technologies
Corporation (“Dynavax” or the “Company”) (Nasdaq: DVAX) concerning
possible violations of federal securities laws.
If you purchased or otherwise acquired shares of Dynavax, and
would like more information regarding the investigation, we
encourage you to contact Michael Goldberg or Brian Schall, of
Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles,
CA 90067, at 800-977-7401, to discuss your rights without cost to
you.
You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation focuses on the U.S. Food & Drug
Administration’s September 2, 2016 announcement that it cancelled
Dynavax’s meeting with the Vaccines and Related Biological Products
Advisory Committee on November 16, 2016, in order to allow time to
review and resolve outstanding issues with the Company’s Biologics
License Application for HEPLISAV-B™. When this news was announced,
shares of Dynavax dropped in value.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161118005657/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024